Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

103 Press Releases
DateTitleCompany
22 Nov 16 Survey Reveals Most People Don't Know Heart Disease Is the No. 1 Killer of People with Type 2 Diabetes Boehringer Ingelheim and Eli Lilly and Company,
Published by
PR Newswire
14 Nov 16 Baricitinib Demonstrates Early Response Compared to Placebo and Significant Improvement Compared to Adalimumab in Patient-Reported Outcomes Eli Lilly and Company,
Published by
PR Newswire
14 Nov 16 New Analyses of Phase 3 Trials Show Improvements in Rheumatoid Arthritis Symptoms Following Treatment with Baricitinib Across Diverse Population of Patients Eli Lilly and Company,
Published by
PR Newswire
11 Oct 16 Lilly to Participate in Credit Suisse 2016 Healthcare Conference Eli Lilly and Company,
Published by
PR Newswire
11 Oct 16 Leading Experts Warn Global Goal to Cure or Treat Alzheimer's Disease By 2025 is at Risk, Offer Solutions to Adjust Course Eli Lilly and Company,
Published by
PR Newswire
05 Oct 16 Lilly Highlights Advancements in its Oncology Portfolio with New Data at ESMO 2016 Eli Lilly and Company,
Published by
PR Newswire
04 Oct 16 Lilly Confirms Date And Conference Call For Third-Quarter 2016 Financial Results Announcement Eli Lilly and Company,
Published by
PR Newswire
31 Aug 16 Jamere Jackson Elected to Lilly Board of Directors Eli Lilly and Company,
Published by
PharmiWeb.com
22 Aug 16 Lilly and AstraZeneca Receive FDA Fast Track Designation for AZD3293, an Investigational Treatment for Early Alzheimer's Disease Eli Lilly and Company,
Published by
PR Newswire
21 Jul 16 Diversity of Lilly's Alzheimer's Disease Pipeline Showcased at the Alzheimer's Association International Conference® 2016 (AAIC® 2016) Eli Lilly and Company,
Published by
PR Newswire
13 Jul 16 Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer Eli Lilly and Company,
Published by
PR Newswire
23 Jun 16 Diabetes Scholars Foundation Announces 2016 Scholarship Recipients Eli Lilly and Company,
Published by
PR Newswire
09 Jun 16 Lilly and American Migraine Foundation Announce $1 Million Grant for Launch of First Patient Registry to Advance Research and Development in Migraine Eli Lilly and Company,
Published by
PR Newswire
01 Jun 16 Lilly Announces Diabetes Commercial Update Investor Call Eli Lilly and Company,
Published by
PR Newswire
31 May 16 Lilly Announces Webcast to Discuss Abemaciclib Data Eli Lilly and Company,
Published by
PR Newswire
31 May 16 U.S. FDA Approves Once-daily Jentadueto® XR (linagliptin and metformin hydrochloride extended-release) Tablets for Adults with Type 2 Diabetes Eli Lilly and Company,
Published by
PR Newswire
10 May 16 Eli Lilly and Company marks 140 years of caring and discovery Eli Lilly and Company,
Published by
PR Newswire
02 May 16 Lilly's Taltz® (ixekizumab) Now Available in the U.S. for the Treatment of Moderate-to-Severe Plaque Psoriasis Eli Lilly and Company,
Published by
PR Newswire
11 Feb 16 Lilly Diabetes Helps Inspiring Students with Type 1 Diabetes Attend College Through Scholarship Donation Eli Lilly and Company,
Published by
PR Newswire
11 Nov 15 Detailed Results Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis Eli Lilly and Company,
Published by
PharmiWeb.com
11 Nov 15 Patients Show Significant Improvement in Signs and Symptoms of Psoriatic Arthritis, Less Progression of Structural Joint Dama... Eli Lilly and Company,
Published by
PharmiWeb.com
03 Mar 16 CHMP Recommends Approval of Lilly’s Ixekizumab [TALTZ®] for the Treatment of Moderate-to-Severe Plaque Psoriasis Eli Lilly and Company ,
Published by
PharmiWeb.com
12 Feb 16 UK Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit Eli Lilly and Company,
Published by
PR Newswire
27 Jan 16 Lilly and Roche Diagnostics to Collaborate on Alzheimer's Disease Adjunct Diagnostic Tool Eli Lilly and Company,
Published by
PR Newswire
04 Apr 16 Lilly Confirms Date and Conference Call for First-Quarter 2016 Financial Results Announcement Eli Lilly and Company,
Published by
PR Newswire
15 Dec 15 Juan R. Luciano elected to Lilly board of directors Eli Lilly and Company,
Published by
PR Newswire
15 Dec 15 Lilly Sets Dates and Conference Calls for 2016 Financial Guidance and Fourth-Quarter 2015 Financial Results Eli Lilly and Company,
Published by
PR Newswire
12 Apr 16 Lilly to Provide Detailed Update of Pipeline and R&D Strategy at Upcoming Investment Community Meeting Eli Lilly and Company,
Published by
PR Newswire
26 Feb 16 Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis Eli Lilly and Company,
Published by
PR Newswire
04 Nov 15 Lilly to Participate in Credit Suisse 2015 Healthcare Conference Eli Lilly and Company,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.